Latest filing published 13 Jan 2024 for Antibe Therapeutics Inc., €8,500.
Jennifer McNealey discloses dealings in Antibe Therapeutics Inc. to SEDI. Over a trading history stretching from 24 November 2020 to 11 January 2024, the count stands at 6 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 13 January 2024, reports an option exercise of €8,500 in Antibe Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations